-
psnet.ahrq.gov/node/47677/psn-pdf
March 13, 2019 - Measuring the rate of manual transcription error in
outpatient point-of-care testing. … Measuring the rate of manual transcription error in outpatient point-of-care testing. … https://psnet.ahrq.gov/issue/measuring-rate-manual-transcription-error-outpatient-point-care-testing … https://psnet.ahrq.gov/issue/measuring-rate-manual-transcription-error-outpatient-point-care-testing
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
September 15, 2005 - What are the benefits of genetic counseling before testing? … What Are the Benefits of Genetic Counseling before Testing? … BRCA1 gene testing. … Genetic testing for cancer susceptibility: indications for genetic testing. SEER Data. … What are the benefits of genetic counseling before testing?
-
www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/cervical-cancer-screening
August 21, 2018 - hrHPV testing with cytology triage. … to hrHPV testing or cotesting. … testing alone and cotesting. … Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical … but not diagnostic (ie, colposcopy and biopsy) testing.
-
www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/CDI-slides.pptx
November 01, 2019 - Antibiotic Use – Acute Care
1
Objectives
Discuss the importance of judicious C. difficile laboratory testing … Testing limited to patients with diarrhea
≥3 unformed stools per day
Confirm patient has not received … a laxative within the prior 48 hours before sending testing
No indication for a test of cure
Over 60% … No repeat testing within 7 days
No testing of formed stool samples
13
Clostridioides difficile
AHRQ … Understand the C. difficile testing approach in your institution and if measures can be undertaken to
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-6kN7TPcfEj2owG4GTN2jA
June 01, 2012 - The benefits of
screening with
co-testing
(cytology/HPV
testing) every 5 years
outweigh the harms … to 65 Years
Women Aged 21 Women Aged 30
HPV testing combined with cytology (co-testing) every 5 years … Among women aged 30 to 65 years, HPV
testing combined with cytology (co-testing) every 5 years
offers … may increase with HPV testing. … Women aged 30 to 65 years should be
screened with cytology and HPV testing (co-testing) every
5 years
-
psnet.ahrq.gov/node/74091/psn-pdf
November 17, 2021 - After testing
positive there for Covid, some never came out.
November 17, 2021
Jewett C. … https://psnet.ahrq.gov/issue/patients-went-hospital-care-after-testing-positive-there-covid-some-never … https://psnet.ahrq.gov/issue/patients-went-hospital-care-after-testing-positive-there-covid-some-never-came-out … https://psnet.ahrq.gov/issue/patients-went-hospital-care-after-testing-positive-there-covid-some-never-came-out
-
digital.ahrq.gov/sites/default/files/docs/resource/Mostashari_List_of_Measures_TCNY_AQA_eQARR_Crosswalk_1_30_08_Mostashari.pdf
June 16, 2021 - HIV Testing Patients 18-64
years of age
with an HIV test
result
Prenatal HIV
Screening
(PCPI) … in
HIV positive
adults
Patients who are
HIV+ who had at
least one viral
load and CD4
testing … Lead Testing-
Age 1
One-year olds
receiving blood
lead testing
Lead Testing-
Age 2 … Two-year olds
receiving blood
lead testing
Lead Testing The percentage of
two-year olds that … A higher rate
represents better
performance (i.e.,
appropriate testing).
-
psnet.ahrq.gov/issue/clinical-impact-associated-corrected-results-clinical-microbiology-testing
December 03, 2008 - Study
Clinical impact associated with corrected results in clinical microbiology testing … Clinical impact associated with corrected results in clinical microbiology testing. … Clinical impact associated with corrected results in clinical microbiology testing. … , 2022
Measuring the rate of manual transcription error in outpatient point-of-care testing … December 3, 2008
Finding blunders in thyroid testing: experience in newborns.
-
psnet.ahrq.gov/issue/laboratory-testing-general-practice-patient-safety-blind-spot
July 29, 2015 - Commentary
Laboratory testing in general practice: a patient safety blind spot. … Laboratory testing in general practice: a patient safety blind spot. … Laboratory testing in general practice: a patient safety blind spot.
-
www.ahrq.gov/hai/tools/ambulatory-surgery/sections/implementation/training-tools/checklist-creating.html
May 01, 2017 - Development
(Before Drafting Your Tool)
→
Drafting
(Before Testing Your Tool)
→
Testing … Takes less than 15 minutes for the observer to fill out
|___| Incorporates any feedback from the testing
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KWfaboZAt9KKoDMQbLvbbt
June 20, 2019 - Reducing Obstetrician Barriers to Offering
HIV Testing. … Update: serologic testing for HIV-1 antibody—United States, 1988 and
1989. … Voluntary HIV testing as part of routine medical care—Massachusetts, 2002. … Routinely recommended HIV testing at an urban urgent-care clinic—At-
lanta, Georgia, 2000. … Prenatal and
perinatal human immunodeficiency virus testing: expanded recommendations.
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-16-p002-1-ef.pdf
May 01, 2016 - Reliability and Validity of the Measure
Reliability testing was performed at three children’s hospitals … Measure Development and Testing
● Feasibility testing of the eMeasure was conducted at four Chicago … ● At all four testing sites, each of the EHR systems had structured fields for all measure criteria … ● In parallel-forms reliability testing of the chart review measure, the clinical performance was … ● Feasibility testing indicated that in hospitals that currently administer the Braden-Q on paper,
-
www.ahrq.gov/ncepcr/care/coordination/atlas/chapter6c.html
June 01, 2014 - Outcomes: 2l
Care management: Care Coordination Needs: 5; Focus Encounter: 7
Development and Testing … : Pilot testing was conducted in several general pediatric practices with varying sizes, locations, … Testing was conducted in association with the Australian Coordinated Care Trials using data from 1193 … Authors suggest that further testing for predictive and concurrent validity is warranted. 1
Link to … Authors suggest that further testing for predictive and concurrent validity is warranted. 1
Link to
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/k-btyK4W2-v9KnemTK8WDx
September 14, 2021 - infection; infection transmission or
acquisition; diagnostic accuracy of anatomical site–specific testing … Sensitivity of
gonococcal testing was 89% or greater for all anatomical samples. … False-positive and
false-negative testing rates were low across anatomical sites and collection methods … Testing for asymptomatic chlamydial and gonococcal infections was
highly accurate at most anatomical … The sensitiv-
ity of urine testing was more variable than anatomical site testing
in 5 studies (range
-
psnet.ahrq.gov/node/73208/psn-pdf
May 05, 2021 - Accuracy of practitioner estimates of probability of
diagnosis before and after testing. … Accuracy of practitioner estimates of probability of diagnosis
before and after testing. … https://psnet.ahrq.gov/issue/accuracy-practitioner-estimates-probability-diagnosis-and-after-testing … https://psnet.ahrq.gov/issue/accuracy-practitioner-estimates-probability-diagnosis-and-after-testing
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TEqfQsqZ92eykPeTQBZx-h
Grade: A
Screen with cytology
every 3 years or
co-testing
(cytology/HPV testing)
every 5 years … Grade: D
Do not screen with
HPV testing (alone or
with cytology)
Grade: D
Risk Assessment … HPV testing combined with cytology (co-testing) every 5 years in women ages 30 to 65 years offers a comparable … The benefits of
screening with co-testing
(cytology/HPV testing)
every 5 years outweigh
the harms … The potential harms of
screening with HPV
testing (alone or with
cytology) outweigh the
potential
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/report/rep7.html
June 01, 2010 - Portions, or even all, of these tools could be used with minimal investment in additional testing and … Second are gaps in testing of applicability of extant measures to a broader array of recipients and settings … measures and supplemental measures for specific populations, settings, and service delivery models, such testing … In contrast, a cross-disability approach argues for more testing and refinement of specialized measure … A related gap is the relative lack of testing of several State-specific tools with items that closely
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/module-5-slides.pdf
December 31, 2022 - and collaborate with IT to develop EMR
specifications for an automatic referral system
3 Create a testing … plan to begin testing your planned approach to
automate referral for cardiac rehabilitation
7 … 35
TEST
Testing Phases
36
Develop Your Testing Plan
37
What testing
phases do you
need … Bench Testing
38
Primary Purpose: Verify that programming to identify eligible patients for referral … Proceeding without rigorous bench testing is a common cause of
implementation failure.
-
psnet.ahrq.gov/web-mm/fatal-oversight-misdiagnosis-nocturnal-chest-pain-elevated-d-dimer
May 01, 2005 - The primary care physician had ordered laboratory testing, which was unremarkable except for a slightly … Stress testing is the modality of choice in determining if a patient’s symptoms are likely secondary … Functional capacity is a substantial and prognostic component of several modalities of stress testing … , such as treadmill stress testing with continuous electrocardiogram monitoring or treadmill stress testing … Myocardial perfusion positron emission tomography stress testing does not rely on functional capacity
-
psnet.ahrq.gov/web-mm/diagnosing-hiv-it-doesnt-take-brain-surgeon
January 01, 2018 - for HIV testing. … Assessing missed opportunities for HIV testing in medical settings. … Trends in HIV testing and differences between planned and actual testing in the United States, 2000-2005 … Voluntary HIV testing as part of routine medical care--Massachusetts, 2002. … Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral.